Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InterCure Ltd. (INCR : NSDQ)

• Company Description    InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK. Number of Employees: 320

• Price / Volume Information    Yesterday's Closing Price: $1.48 Daily Weekly Monthly 20 Day Moving Average: 17,414 shares Shares Outstanding: 45.57 (millions) Market Capitalization: $67.45 (millions) Beta: 1.18 52 Week High: $2.62 52 Week Low: $1.17 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.63% -6.64% 12 Week 17.46% 2.93% Year To Date -6.92% -12.09%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 85 MEDINAT HA-YEHUDIM STREET - HERZLIYA,L3 4676670 ISR ph: 972-77-460-5012 fax: - None http://www.intercure.co

• General Corporate Information    Officers Alexander Rabinovich - Chief Executive Officer and Chairman Amos Cohen - Chief Financial Officer David Salton - Director Lennie Michelson Grinbaum - Director Gideon Hirschfeld - Director Peer Information InterCure Ltd. (BJCT) InterCure Ltd. (CADMQ) InterCure Ltd. (APNO) InterCure Ltd. (UPDC) InterCure Ltd. (IMTIQ) InterCure Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M549GJ111 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 08/20/25 Share - Related Items Shares Outstanding: 45.57 Most Recent Split Date: (:1) Beta: 1.18 Market Capitalization: $67.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/20/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.63 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.73 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.18 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -35.60 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 2.36 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 1.69 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.34 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 25.65

Powered by Zacks Investment Research ©